Table 3.

Treatment changes among the 647 patients by improvement group for skin disease severity and joint disease activity.

All PatientsNo Change in TherapyaReduced TherapyaAt Least 1 Change in TherapyaPatients With ≥ 1 Change in Therapy That Provided a Reason for ChangeDue to EfficacybDue to Other ReasonbDue to SafetybDue to Tolerabilityb
Changes in skin severity and joint activity
  Improved in both5420 (37.0)6 (11.1)28 (51.9)112 (18.2)4 (36.4)3 (27.3)2 (18.2)
  Improve in skin, no change in joints11884 (71.2)9 (7.6)25 (21.2)156 (40.0)5 (33.3)3 (20.0)1 (6.7)
  Improve in joints, no change in skin5414 (25.9)6 (11.1)34 (63.0)125 (41.7)5 (41.7)1 (8.3)1 (8.3)
  No change in either263173 (65.8)18 (6.8)72 (27.4)4427 (61.4)7 (15.9)7 (15.9)3 (6.8)
  Worsen in skin, improve in joints125 (41.7)0 (0.0)7 (58.3)21 (50.0)1 (50.0)0 (0.0)0 (0.0)
  Worsen in joints, improve in skin2212 (54.5)3 (13.6)7 (31.8)76 (85.7)0 (0.0)0 (0.0)1 (14.3)
  Worsen in skin, no change in joints6739 (58.2)6 (9.0)22 (32.8)156 (40.0)3 (20.0)2 (13.3)4 (26.7)
  Worsen in joints, no change in skin3614 (38.9)3 (8.3)12 (66.7)2012 (60.0)3 (15.0)4 (20.0)1 (5.0)
  Worsen in both218 (38.1)3 (14.3)10 (47.6)118 (72.7)1 (9.1)2 (18.2)0 (0.0)
  Total647369 (57.0)54 (8.3)224 (34.6)13773 (53.3)29 (21.2)22 (16.1)13 (9.5)
Changes in skin severity alone
  Improved194116 (59.8)18 (9.3)60 (41.2)3314 (42.4)9 (27.3)6 (18.2)4 (12.1)
  No change353201 (56.9)27 (7.6)125 (35.4)7644 (57.9)15 (19.7)12 (15.8)5 (6.6)
  Worsened10052 (52.0)9 (9.0)39 (39.0)2815 (53.6)5 (17.9)4 (14.3)4 (14.3)
Changes in joint activity alone
  Improved12039 (32.5)12 (10.0)69 (57.5)258 (32.0)10 (40.0)4 (16.0)3 (12.0)
  No change448296 (66.1)33 (7.4)119 (26.6)7439 (52.7)15 (20.3)12 (16.2)8 (10.8)
  Worsened7934 (43.0)9 (11.4)39 (45.6)3826 (68.4)4 (10.5)6 (15.8)2 (5.3)
  • Values are expressed in frequency (%) unless otherwise specified.

  • a Frequency (%) for columns (no change, reduced, or at least 1 change in therapy) are based on a denominator of all patients.

  • b Frequency (%) for columns (reasons due to efficacy, safety, other reason, and tolerability) are calculated based on the number of patients with at least 1 change in therapy and have at least 1 reason given for change. Those who have at least 1 change in therapy and do not give a reason for changing therapy are not included in the denominator for calculating the percentage.